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Abstract
Objectives To explore the feasibility of diffusion-weighted
imaging (DWI) to assess inflammatory lung changes in pa-
tients with Cystic Fibrosis (CF)
Methods CF patients referred for their annual check-up had
spirometry, chest-CT and MRI on the same day. MRI was
performed in a 1.5 T scanner with BLADE and EPI-DWI
sequences (b = 0–600 s/mm2). End-inspiratory and end-
expiratory scans were acquired in multi-row scanners. DWI
was scored with an established semi-quantitative scoring sys-
tem. DWI score was correlated to CT sub-scores for
bronchiectasis (CF-CTBE), mucus (CF-CTmucus), total score
(CF-CTtotal-score), FEV1, and BMI. T-test was used to assess
differences between patients with and without DWI-hotspots.
Results Thirty-three CF patients were enrolled (mean
21 years, range 6–51, 19 female). 4 % (SD 2.6, range 1.5-
12.9) of total CF-CT alterations presented DWI-hotspots.
DWI-hotspots coincided with mucus plugging (60 %), con-
solidation (30 %) and bronchiectasis (10 %). DWItotal-score
correlated (all p<0.0001) positively to CF-CTBE (r=0.757),
CF-CTmucus (r =0.759) and CF-CTtotal-score (r= 0.79); and neg-
atively to FEV1 (r = 0.688). FEV1 was significantly higher
(p<0.0001) in patients without DWI-hotspots.
Conclusions DWI-hotspots strongly correlated with radiolog-
ical and clinical parameters of lung disease severity. Future
validation studies are needed to establish the exact nature of
DWI-hotspots in CF patients.
Key Points
• DWI hotspots only partly overlapped structural abnormali-
ties on morphological imaging
• DWI strongly correlated with radiological and clinical indi-
cators of CF-disease severity
• Patients with more DWI hotspots had lower lung function
values
• Mucus score best predicted the presence of DWI-hotspots
with restricted diffusion.
Keywords Magnetic resonance imaging .Diffusionmagnetic
resonance imaging . Cystic fibrosis . Pulmonary
inflammation . Disease exacerbation
Introduction
Cystic Fibrosis (CF) lung disease is characterized by chronic
airways infection, inflammation, and progressive lung damage
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starting in early childhood [1]. Exacerbations, and acute epi-
sodes of infection and inflammation, eventually lead to end-
stage lung disease, the main cause of death in patients with CF
[2]. Regular monitoring that includes a physical examination,
spirometry, quality-of-life questionnaires and imaging [3], is
used to detect lung changes that require timely treatment [4].
To date, imaging techniques such as chest x-ray (CXR) and
chest-CT (CT) have been the preferred methods for CF mon-
itoring; however, both techniques have limitations [5]. CXR
only allows detection of gross lung changes, such as consol-
idation, atelectasis, and pleural effusion [5]. CT is far more
sensitive to localize and quantify structural changes [6]; how-
ever, short-term follow-up with CT, for example during an
exacerbation, is restricted by radiation exposure [7]. The latter
limitation was the driving force to introduce MRI in CF lung
monitoring [8]. Unfortunately, MRI has inferior sensitivity
compared to CT to detect structural changes in the CF lung
[9, 10] due to a lower spatial resolution. However, more re-
cently the resolution has improved by using newly developed
sequences, such as ultrashort [11] or zero echo time [12].
Furthermore, the interest for using MRI in CF has expanded
towards functional imaging [13]. Multi-parametric MRI, such
as Fourier Decomposition [14], hyperpolarized-gases MRI,
and oxygen-enhanced MRI [15, 16], provide information not
readily available with CT [17]. Diffusion-weighted imaging
(DWI) is another MRI technique that might have great poten-
tial in CF lung monitoring [18]. To date, DWI has been pri-
marily used to assess malignancies in thoracic imaging [19].
Interestingly, DWI has proved to be accurate in the identifica-
tion of inflammation in various organs, such as brain, spine,
muscle, and intestines [20–23]. Based on these studies, we
investigated whether DWI has potential to detect inflammato-
ry changes in CF lung disease.
The main aims of our study were: 1) to explore the feasi-
bility of DWI to detect lung inflammatory changes in CF
patients, and 2) to correlate DWI with radiological and clinical
indicators of CF lung disease severity.
Material and methods
In this multicenter prospective cross-sectional study, patients
with CF scheduled for their routine annual evaluation were
consecutively recruited in two Italian CF centres (Treviso
and Rome) by their treating physicians. At the clinical evalu-
ation, each patient was informed about the study and asked to
participate. When willing to participate, the subject was
scheduled for the study protocol within two weeks from the
visit. The study was approved by the institutional review
board in all participating centres (n. 292/AULSS9 and n.
419/09). All patients underwent a physical examination, spi-
rometry, chest-CT, and chest-MRI on the same day. Inclusion
and exclusion criteria are described in Table 1.
Physical examination and spirometry
Informed consent was obtained, and each patient underwent a
clinical examination, pulse oximetry, and spirometry, prior to
imaging. As part of the clinical exam, heart and respiratory
rate, weight and height were recorded. Spirometry was per-
formed according to the ATS/ERS guidelines [24].
CTand MRI protocol
The routine biennial CT protocol consisted of volumetric end-
inspiratory and end-expiratory low-dose scans in a 16- or 64-
row scanner (SOMATOM Sensation, Siemens, Erlangen,
Germany) using the following parameters: 120 kV for
patients≥35 kg,100 kV for patients<35 kg, mAs 15–40, no
contrast agent, 1 mm collimation, slice thickness 1 mm, re-
construction increment 0.8 mm, pitch 1. Five mm axial and
coronal reformats with kernels B31f, B60f, and B70f were
obtained to match the slice thickness of MR images.
In addition to the routine CT protocol a chest MRI was
performed on the same day. The MRI protocol consisted of
respiratory-triggered scans using a 16 channel torso coil in a
clinical 1.5 T scanner, with the following parameters: axial
and coronal BLADE sequence proton-density (PD)-weight-
ed with navigator (TR/TE/alpha/: ∞/28 ms/90°, in plane res-
olution 1.2×1.2 mm and slice thickness 5 mm) and T2-
weighted axial BLADE sequence (TR/TE/alpha=2000 ms/
27 ms/150°, in plane resolution 3.2×2.5 mm and slice thick-
ness 5 mm). DWI was acquired using a single-shot echo-
planar imaging sequence (EPI) in the axial plane, with gra-
dients equal in all directions (readout, phase, and slice-
section orientations). DWI was obtained with b values of 0
and 600 s/mm2 (TR/TE/alpha =5632 ms/83 ms/90°, slice
thickness 5 mm, gap 0 mm, 2 average). All sequences were
acquired at end-expiration during free-breathing using navi-
gator echoes respiratory triggering. The MRI protocol was
identical in both CF centres, which had the same MRI scan-
ner (MAGNETOM Avanto, Siemens Healthcare, Erlangen,
Germany).
Image analysis
All CT and MRI images were anonymized and evaluat-
ed in random order by two radiologists (P.C. and G.S.),
with 4 years and 1 year of experience in thoracic CT
and MRI scoring, respectively. Both radiologists were
blinded to any clinical information and to each other’s
CT and MRI assessment. Prior to this study, both radi-
ologists were trained in the CF center of Erasmus MC
(Rotterdam, the Netherlands) to the CF-CT and CF-MRI
scoring systems [25], which were used to score the CT
and BLADE MR images [26].The total score is the sum
of the individual sub-scores per lobe of the following
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parameters: bronchiectasis (CF-CTBE); mucus plugging
(CF-CTmucus); air wall thickening (CF-CTAWT); trapped
air (CF-CTTA), and parenchyma (CF-CTPAR) [26]. Sub-
scores and total scores are expressed as % of the max-
imal possible score.
DWI images were scored in random order using a
semi-quantitative scoring approach, which has been used
in previous studies [27–29]. This qualitatively analyzes
the signal intensity of lung lesions with altered signal
intensity (hotspots). Each hotspot was visually graded
on a three-point score scale by signal intensity: score
0, no signal; score 1, weak signal and score 2, strong
signal. Signal intensity was judged using the highest b-
value (b = 600 s/mm2) images, compared to the signal of
the spinal cord. Spinal cord was used as the reference
structure as it has constant high signal intensity on high
b values as a result of the anatomical organization of
the sagittal nerve fascicles, and it is alongside the entire
chest. When the DWI signal of lung parenchymal
hotspots was lower than that of the cord, it was graded
as Bweak^ (DWIweak score, score = 1), whereas if the sig-
nal was greater than or equal to that of the cord it was
graded as Bstrong^ (DWIstrong score, score = 2). The total
DWI score (DWItotal score) is the sum of all weak and
strong hotspots for each of the six lung lobes, with
lingula considered a separate lobe. A quantitative anal-
ysis was not performed based on the poor reliability of
the apparent diffusion coefficient (ADC) maps due to
residual motion and susceptibility-induced distortions.
Following DWI scoring, using fusion technique (Image
Fusion, Siemens Healthcare, Erlangen, Germany) be-
tween DWI and correlated morphological image (axial
BLADE), the anatomical substrate and the distribution
of the DWI hotspots was identified. In uncertain cases,
the CT was used as reference image. The percentage of
structural CT changes presenting hotspots in DWI im-
ages was computed as a ratio between the DWItotal score
and the CF-CTtotal score. Anatomical substrates with
DWI signal were categorized in a similar fashion to
the CF-CT and CF-MRI scoring system (Online
supplement digital content 1).
Statistical analysis
For each patient, the mean DWI score of the two observers
was used to assess frequency and distribution of the anatom-
ical substrates with DWI signal. Inter-observer agreement for
the CF-CT, CF-MRI, and DWI scoring methods was assessed
using the intraclass correlation coefficient (ICC) and Bland-
Altman plots. ICC values between 0.40-0.60; 0.60-0.80; and ≥
0.80 are considered to represent moderate, good, and very
good agreement, respectively.
Pearson’s correlation was used to measure the strength of
the association between DWI score and clinical and radiolog-
ical parameters reflecting disease severity. These parameters
included: forced expiratory volume in one second (FEV1 %
predicted); Body Mass Index (BMI); CF-CTBE; CF-CTmucus;
and CF-CTtotal score. According to Cohen’s criteria,
Table 1 Inclusion / Exclusion criteria for patient selection
Inclusion criteria Exclusion Criteria
• Proven CF as evidenced by positive sweat test or two CF gene mutations
• Scheduled for biennial routine chest-CT scan requested by the attending physician
• Ability to perform reproducible maneuvers for spirometry
• Ability to comply with instructions during CT and MRI examinations
• Age below 6-years
• Chronic oxygen therapy
• Present or recent (two weeks) pulmonary exacerbation
• History of lung transplantation
• Participation in another trial
• Contraindications for MRI
• Proved or possible pregnancy
• Not able or not willing to give informed consent
Table 2 Patients’ characteristics
Mean Standard deviation Range
Clinical parameters
BMI (kg/m2) 19.1 3.4 12.9-29.9
FEV1 % predicted 71.8 25.2 24-113.4
CT scores
CT-BE (%) 22.4 10.6 3.5-43.8
CT-Mucus (%) 21.7 13.7 0-44.4
CF-CT (%) 25.1 11.6 2.7-45.1
DWI scores
Weak DWI score 6.0 5.2 0-17.5
Strong DWI score 6.9 8.4 0-32
Total DWI score 20.4 14.0 1-54
BMI=Body Mass Index, CT-BE= Computed tomography bronchiectasis
sub-score, CF-CT=Cystic Fibrosis Computed Tomography score, CT-
Mucus= Computed tomography mucus plugs sub-score, DWI=
Diffusion Weighted Imaging, FEV1%=Forced expiratory volume in one
second % predicted. All CT score and sub-scores are expressed as a
percentage of the maximum possible score, ranging from 0 (no patholog-
ical findings) to 100 (maximum severity). The maximum possible scores
for CF-CT, CT-BE and CT-mucus sub-scores are 243, 72, and 36, respec-
tively. DWI scores are expressed as mean score of the two observers for
each patient
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correlations with r between 0.10 and 0.29 are considered
weak, between 0.30 and 0.49 moderate and above 0.50 are
strong [30]. Multiple comparisons were adjusted using the
Bonferroni correction. Differences in continuous variables be-
tween patients with and without DWI hotspots were examined
using a Student t-test.
Finally, data were analyzed using a mixed-effects models to
investigate whether there was an association between specific
covariates and the outcomes of interest, while accounting for
the correlation within the same patients [31]. The covariates
tested in the model were BMI, FEV1, sex, CF-CTBE, CF-
CTmucus and score of each observer (score observer 1 versus
Fig. 1 a Bland-Altman for Total
DWI score observer 1 (Obs1)
versus observer 2 (Obs2). Thick
line is the mean, dashed lines are
± 2 standard deviations (SD). b
Identity Plot Total DWI score
observer 1 versus observer 2. The
continuous line is the identity line
(y = 1*x + 0), dashed line is the
correlations line. Note that
observer 2 had higher scores than
observer 1 (mean difference ~ 9)
Eur Radiol (2016) 26:3830–3839 3833
observer 2). The outcome tested for these covariates were:
DWIweak score, DWIstrong score, and DWItotal score. The Akaike
information criterion (AIC) was used to investigate which
model performs better [32]. The lowest AIC coefficient
defines the best model for the given data, and differ-
ences in AIC coefficient greater than 5 points are con-
sidered significant [32]. Differences were statistically
significant if p< 0.05. Statistical analysis was performed
with SPSS (version 20.0, SPSS, Chicago, IL, USA) and
R (version 3.1.3, the R foundation for statistical com-
puting, Vienna, Austria).
Results
After 12 months of recruitment (April 2011- March 2012)
period, thirty-eight consecutively selected patients with CF
(mean age 24 years, range 6–51 years, 22 females) were en-
rolled in the study. Five subjects were excluded for incomplete
study protocol, so eventually thirty-three patients with CF
were used for data analysis. (mean age 21 years, range 6–
51 years, 19 females). Patients’ characteristics, CT and DWI
scores are summarized in Table 2.
Distribution and anatomical substrates of DWI signal
A mean number of 6 (SD 5.2, range 0–17.5) weak and
6.9 (SD 8.4, range 0–32) strong DWI hotspots were
identified. DWI hotspots were distributed in decreasing
order in the right upper lobe (mean 25.4 %, SD 8.4,
range 0–37.9 %), right lower lobe (mean 24.7 %, SD
6.8, range 16.3-50 %), left lower lobe (mean 21.5 %,
SD 6.9, range 10–36.7 %), left upper lobe (mean
13.5 %, SD 3.6, range 6.7-20.6 %), right middle lobe
(mean 8.2 %, SD 5.4, range 0–18.2 %) and lingula
(mean 6.7 %, SD 3.1, 1.5-13.3 %). The most frequent
structural lung alterations as examined on axial BLADE
with either weak or strong DWI signal were mucus
plugging (mean 61 %, SD 35, range 0–100 %), follow-
ed by consolidation (mean 26.5 %, SD 16.8, range 0–
54 %), and bronchiectasis (mean 12.5 %, SD 9.3, range
0–37.5 %). The DWI hotspots pattern only partially o-
verlapped the structural lung changes on morphological
MRI or CT, and only 4 % (SD 2.6, range 1.5-12.9 %)
of total CF-CT structural lung changes presented DWI
hotspots.
Reliability of DWI score
Overall, inter-observer agreement for CF-CT and CF-MRI
sub-scores was good or very good, except for the trapped-air
sub-score. ICCs for CF-CT and CF-MRI are presented as a
table in the online supplement digital content 2BLINDED. Inter-
observer agreements for DWIweak score, DWIstrong score, and
DWItotal score were good: ICC 0.76 (C.I. 95 %, 0.55-0.87),
0.74 (C.I. 95 %, 0.43-0.87) and 0.7 (C.I. 95 %, 0.04-0.89),
respectively. Bland-Altman and identity plots showed that ob-
server 2 had systematically higher DWItotal score scores than
observer 1 (Fig. 1). Bland-Altman and identity plots for total
DWI hotspots identified by each observer are presented as
online supplement digital content 3.
Fig. 2 a Correlation of total diffusion weighted imaging (DWI) score
with total cystic fibrosis computed tomography score (CF-CT score). b
Correlation of total DWI score with forced expiratory volume in 1 second
(FEV1). Continuous lines are correlation lines, dashed lines are 95 %
confidence intervals. Note strong positive correlation of total DWI score
with total CF-CT score (Pearson r = 0.717, p < 0.0001), and strong
negative correlation with FEV1 (Pearson r=− 0.649, p< 0.0001). Mean
score of the two observers was used to build the plots
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Correlations of DWI signal with clinical and radiological
parameters
Total DWI score had strong positive correlation with CF-
CTBE (r=0.757 observer 1, r=0.510 observer 2), CTmucus
(r=0.759 observer 1, r=0.584 observer 2) sub-scores, and
CF-CTtotal score (r=0.790 observer 1, r=0.618 observer 2)
(Fig. 3). DWItotal score had strong negative correlation with
FEV1 (r = − 0.688 observer 1, r = −0.611 observer 2)
(Fig. 2): FEV1 in patients without DWI hotspots (n= 11)
was significantly higher (p<0.0001) than those of patients
with DWI hotspots. BMI did not correlate with DWItotal score
and no significant differences in BMI were found between the
groups with or without hotspots.
Relationship of covariates in DWI scores: mixed-effects
models
For the DWIstrong outcome, the model with the covariate CF-
CTmucus (AIC=398.6) was better than the model with FEV1
(AIC=406.2). However, there were no significant differences
in AIC coefficient between the model with FEV1 or CF-
CTmucus covariates when tested for the DWIweak and
DWItotal score outcomes (DWIweak: AIC-FEV1=367.4, AIC-
CF-CTmucus = 368; DWItotal score: AIC-FEV1=447, AIC-CF-
CTmucus = 446.9). Therefore, we considered the best predictive
model for all three DWI outcomes (weak, strong, and total
DWI) that including CF-CTmucus but not FEV1. The final
model included the covariates: BMI, gender, observer score,
CF-CTBE, and CF-CTmucus. In this model the CF-CTmucus and
observer score covariates were significant for the DWIstrong,
and for DWItotal score. For the DWIweak score outcome, the CF-
CTBE covariate was significant, while CF-CTmucus tended to
be significant (p=0.052). Mixed-effects models results are
summarized in Table 3. Figure 3 shows effect plots for each
DWI score outcome (DWIweak score, DWIstrong score, and
DWItotal score) based on the mixed-effects model analysis.
Discussion
To our knowledge, this is the first study that has used DWI to
assess CF lung disease, and several observations can be made
from these results.
The most important observation is that DWI hotspots
only partially overlapped the structural lung changes as
seen on morphological CT or MRI (Fig. 4). Moreover,
the DWI signal for the same parenchymal abnormality
on MRI in a single patient was very different. For in-
stance, mucous plug as observed on MRI in a lobe
could show different signal intensities, from no signal
to a very intense signal (Fig. 5). Similar variability was
also observed for other structural lung changes, such as
consolidation and bronchiectasis, which were the most
frequent structural lung changes presenting a DWI sig-
nal. We speculate that the observed differences in DWI
signal intensity might be related to the severity of local
inflammation, based on differences in the cellularity of
the structure examined and consequently in differences
in the restriction of proton movement.
Alternative explanations are that increased DWI sig-
nal intensity depend on an increased capillary perfusion
in relation to inflammation, which can be detected by
DWI as D* (pseudo-diffusion coefficient) associated
with blood flow [33]. However, pseudo-diffusion was
not assessed in our MRI protocol, as intravoxel incoher-
ent motion imaging was not applied [34]. Furthermore,
differences in DWI signal intensity (weak vs. strong)
among the structural lung changes could be related to
differences in water concentrations caused by T2-shine-
through artefact [35]. To overcome this, we assessed
Table 3 Effect table for DWI scores outcomes based on the mixed-effects models analysis
DWIweak score DWIstrong score DWItotal score
Value SE p-value Value SE p-value Value SE. p-value
Intercept −1.5241 4.0634 0.7102 8.6896 4.3673 0.0558 16.3902 6.5247 0.0176*
Observer score −0.6208 0.7530 0.4162 −3.0626 1.1507 0.0124* −8.2908 1.6539 <0.0001*
BMI 0.0389 0.2011 0.8480 −0.3395 0.1976 0.0960 −0.1354 0.2905 0.6445
Gender 1.3513 1.3371 0.3203 −0.3958 1.3170 0.7658 0.6968 1.9399 0.7220
CF-CTBE 0.1736 0.0705 0.0197* 0.0645 0.1029 0.5355 0.2021 0.1485 0.1836
CF-CTmucus 0.1113 0.0551 0.0524 0.2304 0.0597 0.0006* 0.2660 0.0831 0.0032*
BMI= Body Mass Index, CF-CTBE=Computed tomography bronchiectasis score, CF-CTmucus= Computed tomography mucus score, FEV1= Forced
expiratory Volume in 1 second % of predicted, SE= Standard Error. Note significant differences in observer score (scores observer 1 vs. observer 2) and
CF-CTmucus covariates for DWIstrong score and DWItotal score outcomes (*). For the DWIweak score outcome, the CF-CTBE is significant (*), while CF-
CTmucus tends to be significant
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and scored the DWI images in the highest b-value
(b = 600 s/mm2), with reduced T2-shine-through effect
(Fig. 5).
The second important finding is that DWI scores
correlated well with radiological and clinical indicators
of CF lung disease severity. DWI scores had a strong
positive correlation with CF-CT score and a moderate
negative correlation with FEV1. In particular, the
higher the DWI score, the higher the CF-CT score, or
the lower the FEV1. These correlations suggest that
patients with more severe CF lung disease have a
larger number of DWI hotspots. This observation is
also supported by the findings that there were signifi-
cant differences in FEV1 between patients with and
without DWI hotspots.
The third important observation is from the mixed-
effects model, which shows that for the DWIstrong out-
come, the best model (lowest AIC coefficient) was the
model that included the CF-CTmucus sub-score instead of
the FEV1 covariate. DWIstrong score represents those
hotspots with high DWI signal, which suggests a re-
stricted diffusion. Paired with the finding that mucus
was also the most frequent alteration associated with
DWI signal, it suggests that mucus significantly contrib-
utes to the Binflammatory^ DWI hotspots in CF lung
disease. This is not unlikely as reduced mucus clearance
is considered to be the primary cause of chronic airway
infection and inflammation in CF [1].
We acknowledge some limitations to this study. First,
we used a semi-quantitative scoring system to assess
DWI signal and did not compute ADC maps. The main
reason was that the ADC maps were not reliable due to
residual motion and susceptibility-induced distortions.
Part of these distortion artefacts was counterbalanced
by doubling the number of averages during image ac-
quisition. More than two averages combined with
respiratory-triggered acquisition were not feasible, as it
would have led to unacceptably long acquisition times
of the DWI sequence (>10 minutes). For these reasons,
we used a semi-quantitative approach that has proved to
be reliable in previous studies, with high sensitivity and
specificity [29]. Moreover, this method showed good
agreement between the observers.
Second, there were significantly different scores be-
tween the observers as shown by the Bland-Altman
plots and by the mixed model analysis (observer score
covariate). However, correlations using the individual
Fig. 3 Effects plots for diffusion-weighted imaging (DWI) scores out-
comes (a) weak, (b) strong, and (c) total DWI score; and CF-CTmucus
covariate. Each plot has two curves, one for each observer. Y-axis repre-
sents DWI scores while x-axis the CF-CTmucus sub-score expressed as %
ofmaximum score, which is 36 for mucus. Each plot simulates changes in
CF-CTmucus sub-score according DWI scores for patients with mean
BMI, mean CF-CTBE sub-score and male gender. For instance, an in-
crease of about 10 % in CF-CTmucus sub-score (c) produces an increase
of DWItotal score of almost 3 points. Note that, although observer 2 has
overall higher total DWI scores (c); the slope of the relation between
DWItotal score and CF-CTmucus sub-score is the same as for observer 1
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scores of each observer instead of taking the mean
scores of both observers obtained the same significant
and concordant results (Table 3). Hence, it is unlikely
that the differences in scores between the observers had
any impact on our most important findings. The devel-
opment of a fully quantitative approach will overcome
this inter-observer limitation, by providing objective
ADC maps that are independent of observer variability.
For now, we are improving the image quality of our
DWI protocol, to facilitate the use of ADC maps for
future studies.
Finally, we did not objectively assess the exact nature
of these DWI hotspots. However, our study had the main
aim to investigate the information obtainable with DWI in
CF lung disease. Clearly, further studies are needed to
validate this technique in CF patients suffering from a
pulmonary tract exacerbation.
Fig. 4 a End-inspiratory axial CT, b) Free-breathing PD-weighted axial
BLADE image, and c) diffusion-weighted imaging (DWI) free breathing
(b = 600 s/mm2). Note that DWI signal (hotspot) only partially overlaps
the left lower lobe consolidation, with the most peripheral portion
presenting the highest signal (arrow). This indicates that the lesion has
non-homogenous DWI characteristics, with the most peripheral portion
having more restricted diffusion
Fig. 5 a End-inspiratory axial CT, b) free-breathing PD-weighted axial
BLADE image, c) Diffusion Weighted Imaging (DWI) free breathing
(b = 0 s/mm2) and D) DWI (b= 600 s/mm2). A large bronchiectasis filled
with mucus can be appreciated in the right lower lobe (arrow in b) Note
heterogeneous DWI signal decay in highest b-value of the mucus-filled
bronchiectasis (arrow in c and d), although it persists in the dorsal branch
due to persistent restricted diffusion (arrowhead in d)
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Conclusions
In summary, this study is the initial exploratory phase towards
the development of DWI as a technique to quantify lung in-
flammation in CF lung disease. We observed that the DWI
hotspots pattern only partly overlapped structural abnormali-
ties on morphological CT or MRI. In addition, DWI scores
had a strong correlation with radiological and clinical indica-
tors of CF lung disease severity. Significant differences in
pulmonary function (FEV1) were found between patients
without and with DWI hotspots. Finally, we found that the
amount of mucus in patients with CF was the best predictor
of strong DWI hotspots (restricted diffusion).
These compelling results have established the foundations
for future validation studies in CF patients with pulmonary
exacerbation, to establish the exact nature of these DWI
hotspots.
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